In a move that will put an exponentially bigger dent in Medicare spending than all radiation costs combined, the first ten drugs (ever) with prices negotiated down anywhere from 25% to 60% have been announced including mainly diabetes drugs and blood thinners but also the CLL therapeutic Imbruvica which has apparently been costing Medicare an outrageous $3 billion annually. | Cohrs and Herper, STAT News 2023
